Nevro sets range for IPO of up to $106m

October 28, 2014 by Brad Perriello

Nevro Corp. sets the per-share price range for its pending initial public offering, which would raise more than $106 million at the high end.

Nevro Corp. set the price range for its forthcoming initial public offering, which would raise $106.3 million at the high end of the range.

Menlo Park, Calif.-based Nevro plans to trade on the NASDAQ exchange under the symbol NVRO, according to a regulatory filing.

Nevro makes an implantable spinal cord stimulation system designed to treat chronic pain it calls Senza. Yesterday the company said it would issue 6.25 million shares at $15 to $17 apiece in the IPO, 1st announced earlier this month. That would mean proceeds of between $93.8 million and $106.3 million, or $100 million at the midpoint of the range.


Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button